Literature DB >> 13643669

[Treatment of psoriasis vulgaris].

W SCHWECKENDIEK.   

Abstract

Entities:  

Keywords:  MALEATES/therapeutic use; PSORIASIS/therapy

Mesh：

Substances：

Year:  1959        PMID： 13643669

Source DB:  PubMed          Journal:  Med Monatsschr        ISSN： 0025-8474


× No keyword cloud information.
  41 in total

1.  Pharmacokinetics of oral fumarates in healthy subjects.

Authors:  Nicolle H R Litjens; Jacobus Burggraaf; Elisabeth van Strijen; Co van Gulpen; Herman Mattie; Rik C Schoemaker; Jaap T van Dissel; H Bing Thio; Peter H Nibbering
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

Review 2.  Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy.

Authors:  Ralf A Linker; Aiden Haghikia
Journal:  Ther Adv Chronic Dis       Date:  2016-06-10       Impact factor: 5.091

3.  Multiple sclerosis: oral BG12 for treatment of relapsing-remitting MS.

Authors:  Volker Limmroth
Journal:  Nat Rev Neurol       Date:  2012-11-13       Impact factor: 42.937

Review 4.  Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases.

Authors:  Francisco J Schopfer; Dario A Vitturi; Diane K Jorkasky; Bruce A Freeman
Journal:  Nitric Oxide       Date:  2018-06-23       Impact factor: 4.427

Review 5.  Mechanism and adverse effects of multiple sclerosis drugs: a review article. Part 2.

Authors:  Aryan Rafiee Zadeh; Keyvan Ghadimi; Akram Ataei; Mozhde Askari; Neda Sheikhinia; Nooshin Tavoosi; Masih Falahatian
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2019-08-15

6.  Anti-Psoriatic Drug Monomethylfumarate Increases Nuclear Factor Erythroid 2-Related Factor 2 Levels and Induces Aquaporin-3 mRNA and Protein Expression.

Authors:  Inas Helwa; Vivek Choudhary; Xunsheng Chen; Ismail Kaddour-Djebbar; Wendy B Bollag
Journal:  J Pharmacol Exp Ther       Date:  2017-05-17       Impact factor: 4.030

7.  [The effect of fumaric acid monoethylester on the synthesis of nucleic acids and proteins of PHA-stimulated human lymphocytes (author's transl)].

Authors:  J Petres; K W Kalkoff; D Baron; R Geiger; I Kunick
Journal:  Arch Dermatol Forsch       Date:  1975

8.  Fumaric Acid and its esters: an emerging treatment for multiple sclerosis.

Authors:  D Moharregh-Khiabani; R A Linker; R Gold; M Stangel
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

9.  Update of the management of chronic psoriasis: new approaches and emerging treatment options.

Authors:  Philip M Laws; Helen S Young
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-04-21

10.  Dimethylfumarate inhibits melanoma cell proliferation via p21 and p53 induction and bcl-2 and cyclin B1 downregulation.

Authors:  Irina Kaluzki; Igor Hrgovic; Tsige Hailemariam-Jahn; Monika Doll; Johannes Kleemann; Eva Maria Valesky; Stefan Kippenberger; Roland Kaufmann; Nadja Zoeller; Markus Meissner
Journal:  Tumour Biol       Date:  2016-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.